AMA says time running down on master agreement drafting deadlineEDMONTON | The president of the Alberta Medical Association is beginning to worry that a promised physician master agreement won’t be hammered out with Alberta Health Services or Alberta Health and Wellness by an end of June deadline. Safinamide disappoints in preventing dyskinesia in Parkinson's patientsThe new drug safinamide might have some impact in preventing the involuntary movements characteristic of Parkinson's disease. However, it did not perform any better than placebo over a two-year period. Alberta conference celebrates centennial Official celebration to mark a century of practice in the province kicks off at Alberta Pharmacy Centennial Conference. Immunotherapy: Ready for prime time in 10 years? Leading researchers are optimistic, but evidence is still too preliminary Byetta: second GLP-1 agonist for diabetes Indicated for use in combination with metformin and/or a sulfonylurea to improve glycemic control in adults with type 2 diabetes. Best medical apps With the help of several physicians we've narrowed the list to nine apps that doctors may deem both beneficial to their practice and which can be accessed via multiple platforms. EMR buying for dummies Ask hard questions, take small steps when implementing an EMR for the first time Ontario getting ready for immunization authority OPA launching new certificate program to teach pharmacists how to provide injections, immunizations. Baked goods may act as immunotherapy for milk-allergic kids Tolerating heated milk a positive prognostic sign for becoming tolerant to all milk products Community pharmacists' role in palliative home care Q: What do you think are some of the key ways that community pharmacists could improve the palliative care of patients in their homes? First Previous 1439 1440 1441 1442 1443 Next Last
